A liquid biopsy is a blood test that more and more oncologists are using to help detect and treat lung cancer. Learn about the different types and what they do.

A new "liquid biopsy" test can help fast-track lung cancer patients to receive targeted therapy up to two weeks earlier, while helping some avoid further tests and treatments, including chemotherapy.

The Business Research Company's Lung Cancer Liquid Biopsy Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 Save 30% On All Global Market Reports With Code ONLINE30 – Stay ...

GeneCentric Therapeutics has secured $8m in new funding to accelerate the development of its RNA-based liquid biopsy platform ...

My mother has been diagnosed with breast cancer, and I’m helping with her medical appointments. Her oncologist says she needs ...

Guardant Health’s first quarter results were driven by strong growth in its core oncology business and continued momentum for ...

The Glasgow, Scotland-based firm's Panaromic Platform uses an infrared spectroscopy-based test with machine learning-developed algorithms to detect signals of cancer.

Caris Life Sciences Inc., a health care company that uses technology to help diagnose and treat cancer, raised $494 million ...

A new review highlights the transformative potential of transfer RNA-derived small RNAs (tsRNAs) in the field of liquid biopsy, emphasizing their ...

About ANGLE plc. ANGLE is a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use in research, drug development an ...

A start-up supported by the C3N-IA Science Park at Universidad Carlos III de Madrid (UC3M) and specialized in oncology, has ...